Chemoinformaics analysis of S-CARBOXYMETHYLCYSTEINE
| Molecular Weight | 179.197 | nRot | 5 |
| Heavy Atom Molecular Weight | 170.125 | nRig | 2 |
| Exact Molecular Weight | 179.025 | nRing | 0 |
| Solubility: LogS | -1.173 | nHRing | 0 |
| Solubility: LogP | -3.368 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 21.5591 |
| nHD | 3 | BPOL | 12.6549 |
| QED | 0.511 |
| Synth | 2.805 |
| Natural Product Likeliness | 0.306 |
| NR-PPAR-gamma | 0.414 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.026 |
| HIA | 0.011 |
| CACO-2 | -6.387 |
| MDCK | 0.00000499 |
| BBB | 0.145 |
| PPB | 0.142461 |
| VDSS | 0.286 |
| FU | 0.777071 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.507 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.148 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.008 |
| CL | 6.79 |
| T12 | 0.805 |
| hERG | 0.023 |
| Ames | 0.016 |
| ROA | 0.033 |
| SkinSen | 0.255 |
| Carcinogencity | 0.235 |
| EI | 0.189 |
| Respiratory | 0.19 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.905009 |